A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some ...

“With low uptake of PrEP among the communities most impacted by HIV, this insurance coverage requirement with ... The new ...

From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...

GILD and partner MRK advance novel investigational combination regimen, a weekly oral HIV treatment, to phase III.

2024 — Scientists have identified promising real-world links between common HIV drugs and a reduced incidence of Alzheimer's ... Scientists Identify Pro-Aging 'Sugar Signature' in the Blood of ...

In recent years the option to purchase medications from India has gained significant popularity offering a reliable and affordable solution for people worldwide India has emerged as a trusted source f ...

Researchers looked at 198 kidney transplants performed at hospitals across the United States. They found similar results ...

With Gilead sprinting to a likely approval next year for its long-acting pre-exposure | With GSK girding for competition from ...

Lenacapavir is a long-acting injectable drug that has proven 100 per cent successful in clinical tests and subsequent human ...

Gilead Sciences, Inc. GILD recently announced additional efficacy, safety and demographic data from its late-stage study on lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, for the ...

ViiV Healthcare, a company specialising in HIV treatment and prevention, yesterday announced that it will provide at least ...

Featuring six shows under one roof – Infrastructure, Roofing Cladding and Insulation Expo (RCI Expo), Build X, Net Zero, Digital Construction, and Onsite On Hire, UKCW Birmingham was sponsored and ...